FundedIQ

Recently Funded Biotechnology Startups in Boston

Updated Sep 2026

FundedIQ holds 110 funded Biotechnology startups in Boston and keeps their funding rounds, amounts, investors, industries, locations and company details up to date. This page provides an overview of the Biotechnology startup funding landscape in Boston, along with the 100 most recently funded Biotechnology startups in Boston.

The median disclosed round is $41M, with the middle half of rounds falling between $12M and $78M. Biotechnology startups in Boston closed 55 funding rounds over the last 24 months, 34 of them in the last 12 months, and raised $2.7B in disclosed capital.

Boston biotechnology firms cluster in early stages with small teams. These lean operations prioritize research over scale. Targets here are typically agile startups with limited staff, making them ideal for specialized vendors who sell to early stage scientists. The dominance of small headcounts indicates a market of emerging players rather than established corporate entities.

Biotechnology funded startup statistics in Boston

Funded Biotechnology startups in Boston
110
tracked in the database
Funding rounds, last 12 months
34
55 over 24 months
Disclosed capital raised, 24 months
$2.7B
47 of 55 rounds disclosed an amount
Median round size
$41M
middle half $12M to $78M

Most recent funding round on record: Sep 2026.

100 most recently funded Biotechnology startups in Boston

100 of 110

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

S
Boston, United States · Biotechnology
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Series B ·
$65M
D
Boston, United States · Biotechnology
Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize…
Series A ·
$30M
B
Boston, United States · Biotechnology
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune…
Series A ·
$126M
P
Boston, United States · Biotechnology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to…
Series Unknown ·
$50M
A
Boston, United States · Biotechnology
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of…
Series A ·
$13M
N
Boston, United States · Biotechnology
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, a intranasal antiviral…
Series Unknown ·
$34M
D
DropGenie
Boston, United States · Biotechnology
DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of…
Seed ·
Undisclosed
S
Boston, United States · Biotechnology
Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein…
Series Unknown ·
$38M
A
Boston, United States · Biotechnology
Ayana Bio is a biotechnology company that produces plant and fungal bioactive ingredients for health and…
Series Unknown ·
$1.3M
C
Boston, United States · Biotechnology
Cerevance is a biotech firm that creates new treatments for neurological disorders, specifically focusing on…
Series C ·
$20M
A
Boston, United States · Biotechnology
Anagram Therapeutics is a clinical stage biopharmaceutical company focused on developing novel, orally…
Series Unknown ·
$250M
E
Endlyz Therapeutics
Boston, United States · Biotechnology
ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function…
Seed ·
Undisclosed
N
Nephronomics
Boston, United States · Biotechnology
Nephronomics is a precision-medicine biotech company focused on cardio-kidney-metabolic (CKM) and primary…
Seed ·
Undisclosed
L
Boston, United States · Biotechnology
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related…
Series D ·
$80M
P
Boston, United States · Biotechnology
Perimeter builds AI-powered systems to detect and fight biological threats like diseases early.
Series Unknown ·
$60M
T
Boston, United States · Biotechnology
TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the…
Series Unknown ·
$6.0M
L
Boston, United States · Biotechnology
Landmark Bio is a biotechnology industry.
Series Unknown ·
$18M
A
Boston, United States · Biotechnology
Allarity Therapeutics is a biopharmaceutical company that focuses on creating cancer treatments that are…
Series Unknown ·
$20M
S
Boston, United States · Biotechnology
Seaport Therapeutics functions as a biopharmaceutical company in the clinical stage of development.
Series Unknown ·
$15M
M
Boston, United States · Biotechnology
Medrhythms is a digital therapeutics company that utilizes sensors, music, and software to develop…
Series Unknown ·
$3.3M
T
Boston, United States · Biotechnology
Third Arc Bio is a biotechnology company that is working on the creation of versatile antibodies for diseases…
Series A ·
$52M
P
Boston, United States · Biotechnology
Precede Biosciences is revolutionizing precision medicine by redefining the knowledge that can be extracted…
Series B ·
$64M
C
Boston, United States · Biotechnology
Carna has a bold mission to be the first to bring the most common clinical whole blood tests into the comfort…
Seed ·
$8.0M
C
Boston, United States · Biotechnology
Corsera Health develops preventive RNA interference medicines focused on reducing cardiovascular disease risk…
Series A ·
$80M
A
Boston, United States · Biotechnology
Allonnia is a waste management company specializing in bioremediation. They develop advanced biotechnology…
Series A ·
$20M
H
Boston, United States · Biotechnology
Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to…
Series Unknown ·
$5.8M
B
Boston, United States · Biotechnology
Bambusa Therapeutics is a biotechnology company that specializes in the development of bispecific antibodies.
Series A ·
Undisclosed
E
Boston, United States · Biotechnology
Elucid, a medical technology company based in Boston, is using advanced AI technology to provide doctors with…
Series Unknown ·
$37M
L
Boston, United States · Biotechnology
Liberate Bio is dedicated to advancing non-viral delivery methods for nucleic acid cargoes like ASOs and…
Seed ·
$31M
M
Boston, United States · Biotechnology
Complex Bio is a biotechnology organization that includes a stage that empowers multiplexed quantitation of…
Series Unknown ·
$1.0M
E
Boston, United States · Biotechnology
Ensoma creates one-time in vivo therapies that precisely modify any type of blood cell as well as immune…
Venture - Series Unknown ·
$53M
A
Boston, United States · Biotechnology
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and…
Series A ·
$50M
D
Boston, United States · Biotechnology
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.…
Series D ·
Undisclosed
C
Boston, United States · Biotechnology
Compass Therapeutics, Inc. is a biopharmaceutical company focused on developing antibody therapies for solid…
Series Unknown ·
$120M
P
Boston, United States · Biotechnology
PathMaker Neurosystems creates treatments for neuromotor disorders using neurotechnology.
Series Unknown ·
Undisclosed
E
Boston, United States · Biotechnology
Eascra Biotech develops Janus-based nanomaterials using DNA nanotechnology that are highly efficient and very…
Series Unknown ·
$100k
S
Boston, United States · Biotechnology
Solu Therapeutics is a company with a focus on precision medicine, dedicated to creating therapeutic…
Series A ·
$41M
A
Boston, United States · Biotechnology
Series B ·
$65M
O
Boston, United States · Biotechnology
Orbit builds non-invasive brain-computer interfaces.
Seed ·
$9.9M
N
Boston, United States · Biotechnology
Newleos Therapeutics is a biotech startup focused on creating neuroscience medications that are both safer…
Series A ·
$94M
A
Boston, United States · Biotechnology
Atalanta Therapeutics is an innovative biotechnology company that is leading the way in developing new…
Series B ·
$97M
I
Boston, United States · Biotechnology
Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on…
Series Unknown ·
$75M
P
Boston, United States · Biotechnology
Propedix is a biopharma and consumer health company dedicated to advancing innovative treatments in…
Seed ·
$800k
B
Boston, United States · Biotechnology
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.…
Series E ·
$60M
G
Boston, United States · Biotechnology
General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first…
Series Unknown ·
Undisclosed
A
Boston, United States · Biotechnology
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and…
Series A ·
$115M
A
Boston, United States · Biotechnology
Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell…
Series Unknown ·
$1.8M
G
Boston, United States · Biotechnology
GC Therapeutics utilizes synthetic biology to efficiently and effectively program patient-derived stem cells…
Series A ·
$65M
E
Boston, United States · Biotechnology
Elektrofi is a preclinical-stage organization devoted to reclassifying the norm of medication conveyance by…
Series C ·
$112M
L
Boston, United States · Biotechnology
Leuko Labs has created a non-invasive device for monitoring white blood cells. Assessing white blood cells is…
Series Unknown ·
$4.5M
S
Boston, United States · Biotechnology
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The…
Series C ·
$150M
A
Boston, United States · Biotechnology
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering…
Series Unknown ·
$1.1M
E
Boston, United States · Biotechnology
Headquartered in Boston’s Seaport community, Entrada Therapeutics is a growing biopharmaceutical company…
Series Unknown ·
$100M
E
Boston, United States · Biotechnology
Elion Therapeutics is an innovative biotechnology company that specializes in treating serious fungal…
Series B ·
$81M
M
Boston, United States · Biotechnology
The BEAR® Implant from Miach Orthopaedics is revolutionising the treatment of anterior cruciate ligament…
Series B ·
$20M
A
Boston, United States · Biotechnology
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape…
Seed ·
$100M
S
Boston, United States · Biotechnology
SmartLabs creates comprehensive research spaces for businesses, encompassing versatile labs for research and…
Series C ·
$48M
E
Boston, United States · Biotechnology
Envoya is a dedicated advocate for providing revolutionary research and technology solutions that have the…
Pre-Seed ·
$2.0M
V
Boston, United States · Biotechnology
Verve Therapeutics is a biotech company that was founded by experts in cardiovascular medicine, genetics, and…
Series Unknown ·
$125M
D
Boston, United States · Biotechnology
DermBiont is a biotech firm focused on creating skin microbiome treatments for the prevention and treatment…
Series B ·
$35M
A
Boston, United States · Biotechnology
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and…
Series Unknown ·
$17M
D
Boston, United States · Biotechnology
Day Zero is revolutionizing infectious disease diagnostics by using advanced technologies like whole-genome…
Series Unknown ·
$16M
H
Boston, United States · Biotechnology
HilleVax, an enterprise specializing in novel vaccine creation and distribution, was established in 2021 and…
Series Unknown ·
$100M
A
Boston, United States · Biotechnology
APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing…
Series Unknown ·
$4.4M
B
Bug Mars
Boston, United States · Biotechnology
Bug Mars utilizes computer vision and machine learning to optimize productivity and profitability in insect…
Series Unknown ·
Undisclosed
P
Boston, United States · Biotechnology
PureTech Ventures is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in…
Series Unknown ·
$11M
N
Boston, United States · Biotechnology
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological…
Series B ·
$87M
X
Boston, United States · Biotechnology
Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision…
Series Unknown ·
$13M
P
Profility
Boston, United States · Biotechnology
Mr. Erez Schachter and his colleagues established Profility Inc. in 2011 with the aim of enhancing healthcare…
Series B ·
Undisclosed
R
Boston, United States · Biotechnology
Rapport Therapeutics is a biotechnology enterprise in the clinical stage, dedicated to discovering and…
Series A ·
$100M
D
DropGenie
Boston, United States · Biotechnology
handling of liquids precisely in biology
Series Unknown ·
Undisclosed
A
Boston, United States · Biotechnology
In order to create a potent anti-tumor vaccination, Alloplex Biotherapeutics is committed to examining the…
Series A ·
$20M
I
Interon
Boston, United States · Biotechnology
New Developments in Neuro-Immunology
Series Unknown ·
Undisclosed
E
Boston, United States · Biotechnology
A privately held pharmaceutical firm called EuMentis Therapeutics Inc. is working on developing and marketing…
Series Unknown ·
$3.0M
P
Boston, United States · Biotechnology
Using its patented Anticalin® technology, clinical-stage biotechnology business Pieris Pharmaceuticals, Inc.…
Series Unknown ·
$5.0M
A
Boston, United States · Biotechnology
Asimov creates methods for controlling live cells. Our multidisciplinary team is improving the development of…
Series B ·
$175M
W
Boston, United States · Biotechnology
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing…
Series Unknown ·
$50M
J
Boston, United States · Biotechnology
Jnana Therapeutics operates as a platform as a service company. The Company specializes in discovering and…
Series C ·
$107M
S
Boston, United States · Biotechnology
Using voice technology, Sonde Health's platform for chronic and mental health disorders can detect and track…
Series B ·
$2.0M
O
Boston, United States · Biotechnology
Series C ·
$55M
C
Carver Biosciences
Boston, United States · Biotechnology
Carver Biosciences is a biotech company focused on the development of CRISPR/Cas13 antivirals.
Seed ·
Undisclosed
A
Boston, United States · Biotechnology
Aldatu Biosciences is a Boston, MA-based, early-stage biotechnology company developing innovative diagnostic…
Grant ·
$3.0M
A
Boston, United States · Biotechnology
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted…
Series A ·
$84M
C
Boston, United States · Biotechnology
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.…
Post-IPO Debt ·
$300M
K
Boston, United States · Biotechnology
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative…
Post-IPO Equity ·
$750M
D
Boston, United States · Biotechnology
Differentiated Therapeutics is to design and develop disease-modifying TPD therapies for patients with unmet…
Seed ·
$5.0M
E
Boston, United States · Biotechnology
Situated in the Boston biotech and medtech center point, Elucid is centered around working on the precision,…
Series B ·
$27M
N
Boston, United States · Biotechnology
NuProbe is a state of the art genomics and sub-atomic diagnostics organization.
Series B ·
$50M
I
Boston, United States · Biotechnology
Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology…
Series B ·
$61M
M
Boston, United States · Biotechnology
Mytide is committed to providing peptides to serve a diverse array of applications. During their beta phase,…
Series A ·
$7.0M
N
Boston, United States · Biotechnology
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support…
Debt Financing ·
$2.5M
D
Boston, United States · Biotechnology
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
Convertible Note ·
$30M
B
Boston, United States · Biotechnology
Boston Technology Research provides innovative regulatory compliance methodology, software tools and services…
Debt Financing ·
$1.0M
P
Boston, United States · Biotechnology
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease…
Post-IPO Equity ·
$125M
H
Boston, United States · Biotechnology
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper…
Series C ·
$100M
E
Boston, United States · Biotechnology
Emulate is a privately held company that creates advanced in vitro models for understanding how diseases,…
Series E ·
$82M
I
Boston, United States · Biotechnology
ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and…
·
$50M
M
Boston, United States · Biotechnology
Motif makes ingredients for the next generation of plant-based and healthy foods. They use fermentation to…
·
$226M
L
Boston, United States · Biotechnology
LikeMinds is a discovery service for identifying new stuff; including movies, books, music, people and…
·
$1.1M
B
Boston, United States · Biotechnology
Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where…
·
$104M

10 more funded startups

110 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to May 2021). The full 110-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 110 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Funding stages of funded Biotechnology startups in Boston

How the last 24 months of funding rounds for funded Biotechnology startups in Boston break down by stage.

A further 22 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in Boston

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 110 funded Biotechnology startups in Boston currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (8 of 55 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in Boston is dated Sep 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in Boston?

FundedIQ tracks 110 funded Biotechnology startups in Boston. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in Boston raised?

Biotechnology startups in Boston tracked by FundedIQ have raised $2.7B in disclosed capital across 55 funding rounds over the last 24 months, including 34 rounds in the last 12 months. 47 of those 55 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in Boston?

The median disclosed round over the last 24 months is $41M, and the middle half of rounds fall between $12M and $78M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in Boston?

Series A is the most common labelled stage, with 15 rounds in the last 24 months, ahead of Seed (9) and Series B (5). A further 22 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in Boston updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in Boston is dated Sep 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.